Centre says 120 adverse events reported after nearly 56 lakh HPV vaccine doses administered, HC refuses to stay drive

4 min readNew DelhiJul 30, 2026 12:19 AM IST A 2017 report by the Global Advisory Committee on vaccine safety that broadly held the vaccine to be safe, had observed, “Despite the extensive safety data available for this vaccine, attention has continued to focus on spurious case reports and unsubstantiated allegations.” The Delhi High Court on Wednesday refused to stay the HPV vaccination drive currently underway across India after it was informed by the Centre that out of around 55.9 lakh doses administered so far since February, only 120 cases reported adverse events following immunisation (AEFI) as on July 25. The court, which was hearing a PIL that flagged concerns over safety of administering Merck’s HPV vaccine Gardasil, noted that there was “no instant harm”.Out of the 120 AEFI cases